Skip to content

Postoperative Pain Management After Total Knee Arthroplasty

Comparison Study of Three Different Methods of Postoperative Pain Management After Total Knee Arthroplasty

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04344990
Enrollment
72
Registered
2020-04-14
Start date
2015-06-29
Completion date
2019-10-30
Last updated
2020-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Arthroplasty, Postoperative Pain

Keywords

epidural analgesia, intra-articular infusion analgesia;, femoral nerve block, total knee arthroplasty

Brief summary

The study compares three different analgesic techniques in order to determine which one serves as the optimal method for postoperative pain management after Total Knee Arthroplasty in patients suffering from Osteoarthritis

Detailed description

Prospective, randomized, controlled study. Approval of the study from the University Hospital of Patras Ethics Committee. The Total Knee Arthroplasty procedure is performed always from the same team of Orthopedic surgeons who follow the same technique in each patient for the arthroplasty and the placement of the intraarticular catheter as well. The same team of Anesthesiologists (two Anesthesiologists) performs always the same technique for each analgesic method and is responsible for the patients' perioperative condition concerning anesthesia and analgesia. Preoperatively, one hour prior to the surgery, all patients receive preemptive multimodal analgesia in the following way; 40mg Parecoxib (iv), 1gr Paracetamol (iv), 150mg Pregabalin (po), 8mg Dexamethasone (iv) και 50mg Ranitidine (iv). All patients receive subarachnoid anesthesia with Ropivacaine 0.75% (7,5mg/ml) in a dosage of 2-3ml titrated according to patient's age and height. Three groups 1. Continuous epidural infusion (control group) with Ropivacaine 0.2% + clonidine 150μg. 2. Continuous femoral nerve blockade infusion with Ropivacaine 0.2% + clonidine 150μg. 3. Continuous intraarticular infusion with Ropivacaine 0.2% + clonidine 150μg. All the catheters remain for 48 hours while the infusion rate is 2ml/h + PCA with 0,5ml/15min and lock-out maximum dose 4/h in total volume of 150ml. Postoperatively all patients also receive; Parecoxib, Paracetamol, Pregabalin, and Ranitidine up to the third postoperative day (doses titrated). Rescue analgesia: Tramadol Chloride 50-100mg x 2 /24h depending on patient's age and medical history.

Interventions

PROCEDUREEpidural analgesia - Group E

Postoperative analgesia with continuous epidural infusion (control group) with Ropivacaine 0.2% + clonidine 150μg with PCA pump (2ml/h and bolus dosage 0,5ml per 15min)

PROCEDUREFemoral blockade - Group F

Postoperative analgesia with continuous femoral nerve blockade infusion with Ropivacaine 0.2% + clonidine 150μg with PCA pump (2ml/h and bolus dosage 0,5ml per 15min) .

PROCEDUREIntraarticular infusion - Group I

Postoperative analgesia with continuous intraarticular infusion with Ropivacaine 0.2% + clonidine 150μg with PCA pump (2ml/h and bolus dosage 0,5ml per 15min)

Sponsors

University Hospital of Patras
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
50 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

1. Patients scheduled for unilateral total knee arthroplasty (TKA) to treat knee osteoarthritis (OA) 2. Fully conversant in the Greek language 3. Written informed consent to participate in the trial

Exclusion criteria

1. Age less than 50 years and greater than 85 years. 2. ASA score \>III 3. Pregnancy 4. Subarachnoid anesthesia failure 5. Hypersensitivity/ allergy to certain agent used 6. Participation in other research/ study 7. Severe mental disease (schizophrenia, major depression, severe bipolar disorder, substance abuse)

Design outcomes

Primary

MeasureTime frameDescription
Postoperative analgesiaUp to 3 daysPain scores, during rest and movement (active and passive) according to NRS (Numeric Rating Scale) right after the end of the surgery and 2, 4, 6, 12, 24, 36, 48, 60 and 72 hours later (postoperatively)

Secondary

MeasureTime frameDescription
MobilizationUp to 3 daysTime of mobilization (standing, walking in room, walking out of room)
LOSUp to 3 monthsLength of hospital stay

Countries

Greece

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026